NO991672L - Fremgangsmaate for fremstilling av hydroksaminsyrer - Google Patents

Fremgangsmaate for fremstilling av hydroksaminsyrer

Info

Publication number
NO991672L
NO991672L NO991672A NO991672A NO991672L NO 991672 L NO991672 L NO 991672L NO 991672 A NO991672 A NO 991672A NO 991672 A NO991672 A NO 991672A NO 991672 L NO991672 L NO 991672L
Authority
NO
Norway
Prior art keywords
procedure
preparation
hydroxamic acids
hydroxamic
acids
Prior art date
Application number
NO991672A
Other languages
English (en)
Norwegian (no)
Other versions
NO991672D0 (no
Inventor
Joel Michael Hawkins
Original Assignee
Pfizer Prod Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer Prod Inc filed Critical Pfizer Prod Inc
Publication of NO991672D0 publication Critical patent/NO991672D0/no
Publication of NO991672L publication Critical patent/NO991672L/no

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C239/00Compounds containing nitrogen-to-halogen bonds; Hydroxylamino compounds or ethers or esters thereof
    • C07C239/08Hydroxylamino compounds or their ethers or esters
    • C07C239/14Hydroxylamino compounds or their ethers or esters having nitrogen atoms of hydroxylamino groups further bound to carbon atoms of hydrocarbon radicals substituted by doubly-bound oxygen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D493/00Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08Bridged systems
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00Drugs for disorders of the respiratory system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00Drugs for skeletal disorders
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/08Antiallergic agents
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00Drugs for disorders of the cardiovascular system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C303/00Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides
    • C07C303/36Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids
    • C07C303/40Preparation of esters or amides of sulfuric acids; Preparation of sulfonic acids or of their esters, halides, anhydrides or amides of amides of sulfonic acids by reactions not involving the formation of sulfonamide groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D309/00Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/04Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
NO991672A 1998-04-10 1999-04-09 Fremgangsmaate for fremstilling av hydroksaminsyrer NO991672L (no)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US8136598P 1998-04-10 1998-04-10

Publications (2)

Publication Number Publication Date
NO991672D0 NO991672D0 (no) 1999-04-09
NO991672L true NO991672L (no) 1999-10-11

Family

ID=22163686

Family Applications (1)

Application Number Title Priority Date Filing Date
NO991672A NO991672L (no) 1998-04-10 1999-04-09 Fremgangsmaate for fremstilling av hydroksaminsyrer

Country Status (38)

Country Link
US (1) US6288246B1 (es)
EP (1) EP0949244A3 (es)
JP (1) JPH11343277A (es)
KR (1) KR100329902B1 (es)
CN (1) CN1232023A (es)
AP (1) AP1203A (es)
AR (1) AR018180A1 (es)
AU (1) AU747629B2 (es)
BG (1) BG64154B1 (es)
BR (1) BR9901089A (es)
CA (1) CA2268680A1 (es)
CO (1) CO5070713A1 (es)
DZ (1) DZ2757A1 (es)
EA (1) EA002777B1 (es)
EG (1) EG22263A (es)
GT (1) GT199900046A (es)
HR (1) HRP990105A2 (es)
HU (1) HUP9901041A3 (es)
ID (1) ID23337A (es)
IL (1) IL129328A0 (es)
IN (1) IN192342B (es)
IS (1) IS5019A (es)
MA (1) MA24831A1 (es)
NO (1) NO991672L (es)
NZ (1) NZ335104A (es)
OA (1) OA11031A (es)
PA (1) PA8469301A1 (es)
PE (1) PE20000418A1 (es)
PL (1) PL332450A1 (es)
SG (1) SG125880A1 (es)
SK (1) SK43699A3 (es)
TN (1) TNSN99052A1 (es)
TR (1) TR199900755A2 (es)
TW (1) TW448147B (es)
UA (1) UA57750C2 (es)
UY (1) UY25460A1 (es)
YU (1) YU18199A (es)
ZA (1) ZA992631B (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9918684D0 (en) 1999-08-09 1999-10-13 Novartis Ag Organic compounds
US6458822B2 (en) 2000-03-13 2002-10-01 Pfizer Inc. 2-oxo-imidazolidine-4-carboxylic acid hydroxamide compounds that inhibit matrix metalloproteinases
GB0103303D0 (en) 2001-02-09 2001-03-28 Novartis Ag Organic compounds
WO2004106319A1 (en) * 2003-05-30 2004-12-09 Pfizer Products Inc. Crystal forms of 4-[4-(4-fluorophenoxy)benzenesulfonylamino]-tetrahydropyran-4-carboxylic acid hydroxyamide
AU2003264355A1 (en) * 2003-08-29 2005-03-29 Basf Aktiengesellschaft Process for production of o-substituted hydroxylamines
CA2933174A1 (en) 2013-12-18 2015-06-25 Brita Lp Filter assembly for filter as you pour filtration
TW202237119A (zh) 2020-12-10 2022-10-01 美商住友製藥腫瘤公司 Alk﹘5抑制劑和彼之用途

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA794723B (en) 1978-09-11 1980-08-27 Univ Miami Anti-hypertensive agents
GB9000725D0 (en) 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
US5552419A (en) * 1993-01-06 1996-09-03 Ciba-Geigy Corporation Arylsulfonamido-substituted hydroxamic acids
US5863949A (en) 1995-03-08 1999-01-26 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
KR20000068248A (ko) 1996-08-23 2000-11-25 디. 제이. 우드, 스피겔 알렌 제이 아릴설포닐아미노 하이드록삼산 유도체
US6303636B1 (en) 1997-02-03 2001-10-16 Pfizer Inc Arylsulfonylamino hydroxamic acid derivatives
CA2299355C (en) 1997-08-08 2005-09-27 Pfizer Products Inc. Aryloxyarylsulfonylamino hydroxamic acid derivatives
PT895988E (pt) 1997-08-08 2002-09-30 Pfizer Prod Inc Derivados do acido arilsulfonilamino-hidroxamico
PA8469401A1 (es) 1998-04-10 2000-05-24 Pfizer Prod Inc Derivados biciclicos del acido hidroxamico

Also Published As

Publication number Publication date
KR19990083051A (ko) 1999-11-25
AU747629B2 (en) 2002-05-16
BR9901089A (pt) 2000-05-30
AP9901503A0 (en) 1999-06-30
IL129328A0 (en) 2000-02-17
EP0949244A2 (en) 1999-10-13
UA57750C2 (uk) 2003-07-15
HUP9901041A3 (en) 2003-02-28
EG22263A (en) 2002-11-30
PA8469301A1 (es) 2000-09-29
AU2369099A (en) 1999-10-21
AR018180A1 (es) 2001-10-31
TW448147B (en) 2001-08-01
KR100329902B1 (ko) 2002-03-22
SG125880A1 (en) 2006-10-30
EA002777B1 (ru) 2002-08-29
OA11031A (en) 2002-02-07
TNSN99052A1 (fr) 2005-11-10
EP0949244A3 (en) 2001-05-30
CO5070713A1 (es) 2001-08-28
YU18199A (sh) 2002-11-15
US6288246B1 (en) 2001-09-11
NZ335104A (en) 2000-10-27
BG64154B1 (bg) 2004-02-27
TR199900755A3 (tr) 1999-11-22
ID23337A (id) 2000-04-05
MA24831A1 (fr) 1999-12-31
PE20000418A1 (es) 2000-05-23
GT199900046A (es) 2000-09-15
CN1232023A (zh) 1999-10-20
BG103319A (en) 2001-08-31
HUP9901041A2 (hu) 2000-03-28
EA199900284A2 (ru) 1999-10-28
UY25460A1 (es) 1999-11-17
NO991672D0 (no) 1999-04-09
AP1203A (en) 2003-09-05
PL332450A1 (en) 1999-10-11
JPH11343277A (ja) 1999-12-14
EA199900284A3 (ru) 2000-04-24
ZA992631B (en) 2000-10-09
SK43699A3 (en) 2000-06-12
DZ2757A1 (fr) 2003-09-15
IN192342B (es) 2004-04-10
IS5019A (is) 1999-10-11
TR199900755A2 (xx) 1999-11-22
HU9901041D0 (en) 1999-06-28
HRP990105A2 (en) 2000-02-29
CA2268680A1 (en) 1999-10-10

Similar Documents

Publication Publication Date Title
PT1070069E (pt) Derivados biciclicos do acido hidroxamico
NO993068L (no) Ny forbindelsesform
NO20011936L (no) Fremgangsmate for fremstilling av citalopram
NO2007004I2 (no) Farmasoytisk akseptabelt salt av mykofenolsyre
PT1150966E (pt) Metodo de preparacao de 5-cianoftalido
NO20003454L (no) FremgangsmÕte for fremstilling av (-)cis-3-hydroksy-1-metyl-4-
NO991672L (no) Fremgangsmaate for fremstilling av hydroksaminsyrer
NO20001777D0 (no) Fremgangsmåte for fremstilling av substituerte 4-fenyl-4- cyanocykloheksankarboksylsyrer
NO996432L (no) Fremgangsmåte for fremstilling av 4-substituert-1H-indol-3- glykosamider
NO983784L (no) Fremgangsmåter for fremstilling av bifenyl-isoksasolsulfonamider
ITMI981796A0 (it) Procedimento per la preparazione di r-(-)-carnitina
NO995388D0 (no) Fremgangsmåte for fremstilling av formylfosfonsyre
NO20012099D0 (no) Fremgangsmåte for fremstilling av 4-arylpiperidin-3- carbinoler og beslektede forbindelser
NO20012266D0 (no) Fremgangsmåte for fremstilling av L-DOPA-etylester
NO980316D0 (no) Fremgangsmåte for fremstilling av polymerisater av N-vinylkarprolaktam
NO991148D0 (no) Fremstilling av 1-butyl-4-piperidinyl-metylamin
NO20003077D0 (no) FremgangsmÕte for fremstilling av klorbenzooksazolen
NO994793L (no) Fremgangsmåte for fremstilling av clavulansyre
EE200100333A (et) Meetod 2-halo-3-nitro-4-aminopüridiini valmistamiseks ja selleks vajalike vaheühendite saamine
NO20012811D0 (no) Fremgangsmåte for fremstilling av p-klorfenyl-propanol- derivat
EE9900404A (et) Arüülaminotriasolopüridiinide valmistamise meetod
NO994977D0 (no) Fremstilling av enantiomerfrie biarylketokarboksylsyrer
NO982975L (no) FremgangsmÕte for fremstilling av fosfatbundne keramer
IT1283641B1 (it) Procedimento per la preparazione di cefalosporine
NO20002476L (no) FremgangsmÕte for fremstilling av formylimidazoler

Legal Events

Date Code Title Description
FC2A Withdrawal, rejection or dismissal of laid open patent application